HOB Biotech Group Corp.,Ltd (SHA:688656)
141.06
+0.04 (0.03%)
Mar 17, 2026, 3:00 PM CST
SHA:688656 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 121.63 | 163.47 | 153.8 | 449.86 |
Trading Asset Securities | - | - | - | 135.23 | 5.01 |
Cash & Short-Term Investments | 76.06 | 121.63 | 163.47 | 289.03 | 454.87 |
Cash Growth | -37.47% | -25.60% | -43.44% | -36.46% | 673.38% |
Accounts Receivable | - | 48.61 | 41.5 | 32.38 | 37.48 |
Other Receivables | - | 2.41 | 3.94 | 5.54 | 3.66 |
Receivables | - | 51.02 | 45.44 | 37.92 | 41.15 |
Inventory | - | 111.22 | 111.22 | 87.8 | 68.2 |
Other Current Assets | - | 8.25 | 8.09 | 8.23 | 5.75 |
Total Current Assets | - | 292.12 | 328.21 | 422.98 | 569.97 |
Property, Plant & Equipment | - | 705.71 | 578.68 | 485.27 | 259.74 |
Other Intangible Assets | - | 10.08 | 11.86 | 12.59 | 12.17 |
Long-Term Accounts Receivable | - | - | 0.05 | 0.1 | 0.62 |
Long-Term Deferred Tax Assets | - | 4.13 | 2.47 | 1.78 | 1.63 |
Long-Term Deferred Charges | - | 12.12 | 11.58 | 16.25 | 10.27 |
Other Long-Term Assets | - | 8.65 | 16.4 | 5.52 | 9.52 |
Total Assets | - | 1,033 | 949.26 | 944.49 | 863.92 |
Accounts Payable | - | 44.59 | 23.91 | 9.37 | 9.37 |
Accrued Expenses | - | 37.98 | 34.98 | 31.06 | 29.4 |
Short-Term Debt | - | 105.07 | 50.02 | 50.01 | 20.02 |
Current Portion of Leases | - | 1.1 | 4.8 | 5.67 | 5.51 |
Current Income Taxes Payable | - | 3.33 | 4.67 | 1.53 | 2.33 |
Current Unearned Revenue | - | 14.45 | 14.62 | 13.33 | 13.54 |
Other Current Liabilities | - | 3.42 | 2.74 | 41.89 | 6.01 |
Total Current Liabilities | - | 209.94 | 135.75 | 152.86 | 86.17 |
Long-Term Debt | - | 8 | - | - | - |
Long-Term Leases | - | 1.53 | 1.03 | 9.74 | 5.35 |
Long-Term Unearned Revenue | - | 1.2 | 1.74 | 2.49 | 2.4 |
Long-Term Deferred Tax Liabilities | - | - | - | 0.04 | 0 |
Total Liabilities | - | 220.67 | 138.52 | 165.13 | 93.92 |
Common Stock | - | 63.06 | 63.06 | 63.06 | 63.06 |
Additional Paid-In Capital | - | 562.98 | 553.46 | 550.62 | 549.35 |
Retained Earnings | - | 205.82 | 193.92 | 165.51 | 157.49 |
Treasury Stock | - | -20.01 | - | - | - |
Comprehensive Income & Other | - | 0.29 | 0.29 | 0.18 | 0.1 |
Shareholders' Equity | 829.05 | 812.14 | 810.73 | 779.36 | 770 |
Total Liabilities & Equity | - | 1,033 | 949.26 | 944.49 | 863.92 |
Total Debt | 72.6 | 115.69 | 55.86 | 65.43 | 30.88 |
Net Cash (Debt) | 3.46 | 5.93 | 107.61 | 223.6 | 423.99 |
Net Cash Growth | -41.70% | -94.49% | -51.88% | -47.26% | 2762.22% |
Net Cash Per Share | 0.05 | 0.09 | 1.68 | 3.54 | 6.89 |
Filing Date Shares Outstanding | 66.1 | 62.26 | 62.72 | 63.06 | 63.06 |
Total Common Shares Outstanding | 62.68 | 62.26 | 63.06 | 63.06 | 63.06 |
Working Capital | - | 82.18 | 192.46 | 270.12 | 483.8 |
Book Value Per Share | 13.23 | 13.04 | 12.86 | 12.36 | 12.21 |
Tangible Book Value | 818.04 | 802.06 | 798.87 | 766.77 | 757.83 |
Tangible Book Value Per Share | 13.05 | 12.88 | 12.67 | 12.16 | 12.02 |
Buildings | - | 1.25 | 20.53 | 20.53 | 17.34 |
Machinery | - | 848.29 | 249.06 | 214.57 | 167.93 |
Construction In Progress | - | 4.83 | 422.97 | 325.75 | 128.88 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.